Volume Pricing
Research Overview
Semaglutide is a synthetic GLP-1 receptor agonist engineered for extended stability and receptor selectivity. It is one of the most referenced incretin compounds in modern metabolic research.
Preclinical and clinical research has examined semaglutide across glycemic-control, satiety, and body-composition endpoints, establishing it as a cornerstone reference compound in metabolic-research models.
Research Focus
Mechanism (Research Context)
Semaglutide is studied for its selective activation of the GLP-1 receptor, where it is observed to influence insulin secretion, gastric emptying, and satiety signaling in metabolic-research models.
Intended Use
This compound is strictly intended for in vitro laboratory research. It is not for use in humans or animals. Not to be used in foods, drugs, or medical diagnostics.
Legal Disclaimer
This product has not been evaluated by the FDA. It is not intended to diagnose, treat, cure, or prevent any disease. Usage is restricted to certified laboratories and qualified research professionals.
Terms of Sale
All sales by Codex Research are final. Buyers must be qualified professionals and assume full responsibility for safe handling and regulatory compliance. Every batch is independently verified by accredited third-party laboratories. Batch-specific Certificates of Analysis are available on our COAs page.
For Research Use Only · Not for Human Consumption



















Reviews
There are no reviews yet.